Cargando…
Tumor organoids to study gastroesophageal cancer: a primer
Gastroesophageal cancers are leading causes of cancer death. Our attempts at adopting molecularly based treatment approaches have been slow and ineffective even though we begin to identify specific targetable gene mutations and pathways. It is clear that we should no longer treat all gastroesophagea...
Autores principales: | Jin, Ramon U, Mills, Jason C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683018/ https://www.ncbi.nlm.nih.gov/pubmed/32652008 http://dx.doi.org/10.1093/jmcb/mjaa035 |
Ejemplares similares
-
Gastric Organoids: Progress and Remaining Challenges
por: Pang, Min-Jiao, et al.
Publicado: (2021) -
Immunotherapy for Gastroesophageal Cancer
por: Goode, Emily F., et al.
Publicado: (2016) -
Circulating Tumor DNA in Gastric and Gastroesophageal Junction Cancer
por: Paschold, Lisa, et al.
Publicado: (2022) -
Primer on tumor immunology and cancer immunotherapy
por: Harris, Timothy J, et al.
Publicado: (2013) -
Tumor organoids for cancer research and personalized medicine
por: Yang, Hui, et al.
Publicado: (2022)